Article Text

Download PDFPDF
Randomised controlled trial
Coronary-artery bypass surgery plus medical therapy is associated with longer survival over 10 years than medical therapy alone in patients with ischaemic cardiomyopathy
  1. Akira Marui
  1. Correspondence to Dr Akira Marui, 69–306 Okazaki-Ten'no, Sakyo, Kyoto 606-8335 Japan; akiramarui78{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: OpenUrlCrossRefPubMed.


The efficacy of coronary artery bypass grafting (CABG) in patients with ischaemic cardiomyopathy with low ejection fraction has long been controversial. However, few studies were available that compared the outcomes after CABG with medical therapy in those patients. These studies demonstrated long-term survival benefit of CABG compared with medical therapy alone. However, most of them were performed more than 40 years ago with small sample size before establishing current guideline-based medical therapy.1–3 Recently, the Surgical Treatment for Ischemic Heart Failure (STICH) study investigated whether CABG plus guideline-based medical therapy for ischaemic cardiomyopathy would improve survival compared with medical therapy alone.4 ,5 As a result, the STICH investigators reported that there was no significant difference between …

View Full Text


  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.